Follow-The-Filings

ASND position history

The shares of Ascendis Pharma A/S (ASND) that BAMCO Inc (Baron Capital) reported in each quarter’s 13F.

Equity · SPONSORED ADR

Shares held by quarter

New Add Reduce Exit

  1. 2021 Q4 · 20,500 shares · $3M · <0.01% of portfolio · New
  2. 2022 Q1 · not held · Exit
  3. 2022 Q2 · not held
  4. 2022 Q3 · 7,500 shares · $774K · <0.01% of portfolio · New
  5. 2022 Q4 · 35,306 shares · $4M · 0.01% of portfolio · Add +370.7%
  6. 2023 Q1 · 35,306 shares · $4M · 0.01% of portfolio
  7. 2023 Q2 · not held · Exit
  8. 2023 Q3 · not held
  9. 2023 Q4 · not held
  10. 2024 Q1 · not held
  11. 2024 Q2 · not held
  12. 2024 Q3 · not held
  13. 2024 Q4 · not held
  14. 2025 Q1 · not held
  15. 2025 Q2 · not held
  16. 2025 Q3 · 5,600 shares · $1M · <0.01% of portfolio · New
  17. 2025 Q4 · 5,600 shares · $1M · <0.01% of portfolio
  18. 2026 Q1 · 5,600 shares · $1M · <0.01% of portfolio
  19. 2026 Q2 · not held · Exit
Holdings date Value % of holdings Shares Filing date All 13F holders